Wells Fargo’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-84,506
Closed -$509K 7273
2019
Q4
$509K Sell
84,506
-10,895
-11% -$63.1K ﹤0.01% 4349
2019
Q3
$343K Buy
95,401
+15,621
+20% +$60.2K ﹤0.01% 4626
2019
Q2
$214K Sell
79,780
-20,766
-21% -$61.3K ﹤0.01% 4941
2019
Q1
$298K Buy
100,546
+4,581
+5% +$11.3K ﹤0.01% 4628
2018
Q4
$152K Sell
95,965
-5,479
-5% -$15.5K ﹤0.01% 5082
2018
Q3
$373K Sell
101,444
-17,667
-15% -$52.7K ﹤0.01% 4639
2018
Q2
$337K Buy
119,111
+1,969
+2% +$6.71K ﹤0.01% 4728
2018
Q1
$435K Sell
117,142
-14,052
-11% -$46K ﹤0.01% 4495
2017
Q4
$378K Sell
131,194
-65,344
-33% -$237K ﹤0.01% 4591
2017
Q3
$882K Sell
196,538
-23,109
-11% -$103K ﹤0.01% 3936
2017
Q2
$1.01M Buy
219,647
+3,827
+2% +$15.4K ﹤0.01% 3722
2017
Q1
$908K Buy
215,820
+22,931
+12% +$95.2K ﹤0.01% 3821
2016
Q4
$797K Buy
192,889
+44,209
+30% +$235K ﹤0.01% 3869
2016
Q3
$1.2M Sell
148,680
-15,334
-9% -$130K ﹤0.01% 3357
2016
Q2
$1.28M Sell
164,014
-19,781
-11% -$170K ﹤0.01% 3303
2016
Q1
$1.42M Sell
183,795
-51,054
-22% -$374K ﹤0.01% 3168
2015
Q4
$2.53M Sell
234,849
-14,881
-6% -$135K ﹤0.01% 2817
2015
Q3
$1.73M Sell
249,730
-35,664
-12% -$291K ﹤0.01% 3105
2015
Q2
$2.53M Sell
285,394
-2,554,546
-90% -$24.2M ﹤0.01% 2917
2015
Q1
$28M Buy
2,839,940
+2,505,796
+750% +$31.3M 0.01% 1117
2014
Q4
$4.09M Buy
334,144
+64,541
+24% +$788K ﹤0.01% 2490
2014
Q3
$2.69M Buy
269,603
+11,791
+5% +$109K ﹤0.01% 2807
2014
Q2
$1.95M Buy
257,812
+18,463
+8% +$73.7K ﹤0.01% 3022
2014
Q1
$787K Buy
239,349
+224,332
+1,494% +$785K ﹤0.01% 3634
2013
Q4
$50K Sell
15,017
-1,534,969
-99% -$4.45M ﹤0.01% 4752
2013
Q3
$4.68M Sell
1,549,986
-843,151
-35% -$5.78M ﹤0.01% 2242
2013
Q2
$19.6M Buy
+2,393,137
New +$18.3M 0.01% 1163